'DARROW''S SOLUTION' 'DARROW''S SOLUTION' RINGOLACT RINGOLACT DARROWS SOLUTION PERITONEAL DIALYSIS SOLN WITH DEXTROSE PERITONEAL DIALYSIS SOLN WITH DEXTROSE DARROWS SOLN. DARROWS SOLUTION RINGERS LACTATED RINGERS LACTATED PERI SOLUTION RINGOLACT-D RINGOLACT-D SOLVEIN RINGER MEDISOL (RINGERS LACTATED) MEDISOL (RINGERS LACTATED) LACSOL LACTATED R LACSOL LACTATED R LACTATED RINGERS LACTATED RINGERS SODIUM LACTATE 1/6 MOLAR SODIUM LACTATE 1/6 MOLAR HARTMANN`S SOLUTION HARTMANN`S SOLUTION RINGERS LACTATED RINGERS LACTATED MACROLATE R/L MACROLATE R/L SOLVEIN RINGARS D SOLVEIN RINGARS D SOLVEIN ISO

. It is of Synthetic origin and belongs to Sodium salt. . The Molecular Weight of Sodium Lactate is 112.10. It is weakly acidic drug.

Sodium Lactate is contraindicated in conditions like Lactic acidosis,Hypernatremia.

The severe or irreversible adverse effects of Sodium Lactate, which give rise to further complications include Tissue necrosis, Oedema, Hypernatremia.The symptomatic adverse reactions produced by Sodium Lactate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Hypokalemia, Metabolic alkalosis, Tetany, Reaction at injection site, Hypervolemia.

Sodium Lactate is primarily indicated in conditions like Hypokalaemia, Metabolic acidosis, Peritoneal dialysis.

No data regarding the interactions of Sodium Lactate was found.

Drug should not be given to Cardiac / Hypertensive Patients, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj Store in a well closed container, Below 40°C. Do not Freeze.

During sodium lactate administartion the acid-base status of a patient should be assessed periodically to minimize the possibility of overdosage or metabolic alkalosis. Because of the high sodium content of sodium lactate, the drug should be used with extreme caution in patients receiving corticotropin or corticosteroids, in patients with renal disease or insufficiency, or in patients with congestive heart failure or other sodium-retaining conditions. The drug also should be used cautiously in patients with conditions of impaired utilization of lactic acid such as beriberi, hepatic disease or insufficiency, shock, congestive heart failure, or hypoxemia. Sodium lactate therapy should be used with extreme caution in patients with potassium depletion.The drug should be used with extreme caution in pregnant women.